ライフサイエンスコーパス: behavior therapy

1 rs) and non-pharmacotherapy (e.g., cognitive-behavior therapy).

2 requires effective treatment options beyond behavior therapy.

3 h poor response to medications and cognitive behavior therapy.

4 that included multiple elements of cognitive behavior therapy.

5 guided self-help, an adaptation of cognitive behavior therapy.

6 strongly to the ideal prototype of cognitive behavior therapy.

7 sions and hallucinations following cognitive behavior therapy.

8 lorie diet, increased physical activity, and behavior therapy.

9 treatment of bulimia nervosa with cognitive behavior therapy.

10 atment outcomes for imipramine and cognitive behavior therapy.

11 ) consisting of diet, physical activity, and behavior therapy.

12 were relatively less responsive to cognitive behavior therapy.

13 3 weeks with intensive individual cognitive behavior therapy.

14 tation of the skills emphasized in cognitive behavior therapy.

15 skills training, play therapy, and cognitive behavior therapy.

16 with major depressive disorder to cognitive behavior therapy.

17 escitalopram and poor response to cognitive behavior therapy.

18 with combination escitalopram and cognitive behavior therapy.

19 /d) or 16 sessions of manual-based cognitive behavior therapy.

20 tch to a different medication plus cognitive behavior therapy.

21 RI or venlafaxine, with or without cognitive behavior therapy.

22 nal and social rhythm therapy, and cognitive behavior therapy.

23 arly diagnosis is critical to the outcome of behavior therapies.

24 primary analysis: 12 remitters to cognitive behavior therapy, 11 remitters to escitalopram, 9 nonres

25 ivational enhancement therapy plus cognitive behavior therapy (12 sessions over 6 months), or usual c

26 for a second testing session after cognitive behavior therapy; 13 comparison children participated a

27 Before and after 7-week group behavior therapy, 17 patients with DSM-III-R OCD were as

28 bined) was significantly lower for cognitive behavior therapy (22%) than for nutritional counseling (

29 ropout rate was similar to regular cognitive behavior therapy (30%) and unrelated to treatment arm.

30 tly more of the patients receiving cognitive behavior therapy (44%) than nutritional counseling (7%).

31 gher rate than the group receiving cognitive behavior therapy (53% versus 22%).

32 gher proportion of patients in the cognitive behavior therapy (71%) and supportive stress-management

33 hose who completed self-management cognitive behavior therapy achieved high-end state functioning at

34 ls and other human disorders suggesting that behavior therapy acts by way of long-term potentiation o

35 The effects of dialectical behavior therapy adapted for the treatment of binge/purg

36 The use of dialectical behavior therapy adapted for treatment of bulimia nervos

37 A course of cognitive behavior therapy, added to the antipsychotic regimen, is

38 t to evaluate the effect of online cognitive behavior therapy (AF-CBT) on QoL in patients with sympto

39 -effective compared with in-person cognitive behavior therapy alone.

40 s are treated with similar symptom-relieving behavior therapies and medications.

41 triking contrast to 1 year PTTE in cognitive behavior therapy and < 1 week PTTE in serotonin antagoni

42 tation strategy for exposure-based cognitive behavior therapy and (2) conducted in humans diagnosed a

43 n the follow-up study: 25 received cognitive behavior therapy and 28 received relaxation therapy.

44 f 68% of the patients who received cognitive behavior therapy and 36% who received relaxation therapy

45 "Maximizing the Efficacy of Cognitive Behavior Therapy and Contingency Management", registrati

46 therapy, and treatments combining cognitive behavior therapy and contingency management.

47 Cognitive behavior therapy and graded exercise can be effective in

48 The relation between response to cognitive behavior therapy and HPA activity was not explained by c

49 Dialectical behavior therapy and interpersonal psychotherapy may als

50 promising, as is a combination of cognitive-behavior therapy and morning bright light.

51 CALM (cognitive behavior therapy and pharmacotherapy medication recommen

52 Overall, behavior therapy and pharmacotherapy produce similar sho

53 CALM (cognitive behavior therapy and pharmacotherapy recommendations) an

54 ) was associated with remission to cognitive behavior therapy and poor response to escitalopram, whil

55 Psychotherapies, most notably dialectical behavior therapy and psychodynamic approaches, are effec

56 Psychotherapy with dialectical behavior therapy and psychodynamic therapy are first-lin

57 Psychotherapy such as dialectical behavior therapy and psychodynamic therapy reduce sympto

58 Both cognitive behavior therapy and supportive stress management are ef

59 e constructs across six domains; dialectical behavior therapy and supportive treatment were associate

60 is argues for additional approaches, such as behavior therapy and/or longer duration of hormone thera

61 luding habit reversal or acceptance-enhanced behavior therapy) and medication (serotonin reuptake inh

62 o escitalopram, 9 nonresponders to cognitive behavior therapy, and 6 nonresponders to escitalopram.

63 ed with motivational interviewing, cognitive behavior therapy, and family intervention over routine p

64 ed with motivational interviewing, cognitive behavior therapy, and family or caregiver intervention.

65 ivational enhancement therapy (MET)/CBT, MET behavior therapy, and pharmacological treatment.

66 pics were social anxiety disorder, cognitive behavior therapy, and randomized controlled trial.

67 ement, relapse prevention, general cognitive behavior therapy, and treatments combining cognitive beh

68 Dialectical behavior therapy appears to be uniquely effective in red

69 a psychological treatment based on cognitive behavior therapy, appears ineffective, but treatment wit

70 Although grief-focused cognitive behavior therapies are the most empirically supported tr

71 utamatergic pathways and that the effects of behavior therapy are potentiated by an NMDA agonist.

72 for panic disorder, exposure-based cognitive behavior therapy, are reviewed, and their application to

73 While treatment guidelines recommend behavior therapy as a first-line intervention, patients

74 the first empirical evaluation of cognitive behavior therapy as a posthospitalization treatment for

75 year of diagnosis, including medication and behavior therapy as defined by billing codes.

76 aimed to evaluate whether blended cognitive behavior therapy (bCBT) can reduce the severity of FCR i

77 tion; n = 32 with complete data) or Internet behavior therapy (behavior therapy; n = 33 with complete

78 vioral interventions, specifically brain-gut behavior therapies (BGBTs), in patients with disorders o

79 d with obese adolescents in combination with behavior therapy (BT).

80 comprehensive program of diet, exercise, and behavior therapy but are typically prescribed with minim

81 cognitive behavior therapy favored cognitive behavior therapy, but tests comparing the two modalities

82 nin reuptake inhibitors (SRIs) and cognitive behavior therapy by exposure and ritual prevention are b

83 Cognitive behavior therapy (CBT) among youth with obsessive-compul

84 mized controlled trial comparing a cognitive behavior therapy (CBT) and pharmacotherapy intervention

85 Cognitive behavior therapy (CBT) can be effective for late-life ge

86 ve effectiveness of sertraline and cognitive behavior therapy (CBT) for depression, quality of life,

87 l effectiveness of protocol-driven cognitive behavior therapy (CBT) for insomnia, delivered by oncolo

88 ffectiveness of family therapy and cognitive behavior therapy (CBT) guided self-care in adolescents w

89 Cognitive behavior therapy (CBT) has been established as efficacio

90 Cognitive behavior therapy (CBT) has been identified as the treatm

91 Grief-focused cognitive behavior therapy (CBT) has been shown to be effective in

92 Suicide-specific cognitive behavior therapy (CBT) is effective for reducing suicide

93 Cognitive behavior therapy (CBT) is effective in the treatment of

94 ation with short-term OCD-specific cognitive behavior therapy (CBT) may provide additional benefit.

95 nd, randomized controlled trial of cognitive behavior therapy (CBT) versus usual care (UC) for major

96 fluoxetine hydrochloride therapy, cognitive behavior therapy (CBT), and their combination in adolesc

97 epression, clinicians should offer cognitive behavior therapy (CBT), behavioral activation (BA), MBSR

98 wn for family therapy, followed by cognitive behavior therapy (CBT), motivational enhancement therapy

99 ake inhibitor (SSRI) sertraline or cognitive behavior therapy (CBT), participants completed an emotio

100 d depressed individuals respond to cognitive behavior therapy (CBT).

101 ital recovery support for adjuvant cognitive behavior therapy (CBT).

102 ersonal and social rhythm therapy, cognitive behavior therapy [CBT], or family-focused therapy), and

103 "Computer-Based Training in Cognitive Behavior Therapy (CBT4CBT)", registration number: NCT014

104 BWL) and guided self-help based on cognitive behavior therapy (CBTgsh) have both resulted in short-te

105 Computer-assisted cognitive behavior therapy (CCBT) has been proposed as a method fo

106 ses in binge/purge behavior with dialectical behavior therapy compared to the waiting-list condition.

107 Cognitive behavior therapy compared with EUC significantly improve

108 Grief-focused cognitive behavior therapy comprised 5 sessions of recalling memor

109 ] female), 50 in the grief-focused cognitive behavior therapy condition and 50 in the mindfulness-bas

110 of treatment, participants in both cognitive behavior therapy conditions had significant reductions i

111 the antidepressant medication and cognitive behavior therapy conditions of the Treatment of Depressi

112 In this study, grief-focused cognitive behavior therapy conferred more benefit for core prolong

113 Dialectical behavior therapy (DBT) is a treatment for suicidal behav

114 Dialectical behavior therapy (DBT) is an empirically supported treat

115 Limited evidence suggests that dialectical behavior therapy (DBT) reduces suicidal ideation compare

116 ared the efficacy of 6 months of dialectical behavior therapy (DBT) to 6 months of selective serotoni

117 Extinction, the laboratory analog of behavior therapy, does not erase conditioned fear memori

118 on after 12 weeks of treatment withcognitive behavior therapy, duloxetine, or escitalopram were prosp

119 forms of psychotherapy other than cognitive behavior therapy, even though there is little informatio

120 durable, with 87% of available responders to behavior therapy exhibiting continued benefit 6 months f

121 aring antidepressant medication to cognitive behavior therapy favored cognitive behavior therapy, but

122 The manual-based dialectical behavior therapy focused on training in emotion regulati

123 to either escitalopram oxalate or cognitive behavior therapy for 12 weeks.

124 randomized clinical trial of medication and behavior therapy for ADHD but transitioned to a longitud

125 ents the effects of exposure-based cognitive behavior therapy for anxiety, obsessive-compulsive, and

126 acebo in augmenting the effects of cognitive behavior therapy for anxiety, obsessive-compulsive, and

127 s who will and will not respond to cognitive behavior therapy for bulimia nervosa, potentially allowi

128 Cognitive behavior therapy for chronic fatigue syndrome can produc

129 The availability of behavior therapy for individuals with Tourette syndrome

130 Although cognitive behavior therapy for insomnia (CBT-I) has been establish

131 reports on an open-label trial of cognitive behavior therapy for insomnia and disturbing dreams in c

132 ing, problem solving, assertion training and behavior therapy for insomnia), and conducting a master

133 Components of cognitive behavior therapy for insomnia, especially stimulus contr

134 amatergic receptor, enhances the efficacy of behavior therapy for obsessive-compulsive disorder (OCD)

135 of changes in caudate nucleus function with behavior therapy for obsessive-compulsive disorder.

136 e use of D-cycloserine as an augmentation of behavior therapy for OCD and extend findings in animals

137 Five aspects of cognitive behavior therapy for schizophrenia are addressed: 1) evi

138 road perspective on the subject of cognitive behavior therapy for schizophrenia for the American read

139 trength of the evidence supporting cognitive behavior therapy for schizophrenia suggests that this te

140 ice and data supporting the use of cognitive behavior therapy for schizophrenia.

141 irical evidence, to be superior to cognitive behavior therapy for the acute treatment of severely dep

142 support the efficacy of pharmacotherapy and behavior therapy for the treatment of insomnia, no meta-

143 dy of evidence supports the use of cognitive behavior therapy for the treatment of schizophrenia.

144 combination of diet, physical activity, and behavior therapy (frequently referred to as lifestyle mo

145 Dialectical behavior therapy (g = 0.34; 95% CI, 0.15-0.53) and psych

146 Participants in the grief-focused cognitive behavior therapy group also demonstrated greater reducti

147 ivational enhancement therapy plus cognitive behavior therapy group and -0.19% (CI, -0.53% to 0.16%)

148 The behavior therapy group lost a mean (SD) of 4.0 (2.8) kg

149 Repeated-measures analyses showed that the behavior therapy group lost more weight than the educati

150 Participants in the behavior therapy group received additional behavioral pr

151 participants in the grief-focused cognitive behavior therapy group showed greater reduction in PG-13

152 waist circumference were also greater in the behavior therapy group than in the education group at bo

153 were employed, but patients in the cognitive behavior therapy group worked significantly more mean ho

154 Cognitive behavior therapy had greater and more durable effects th

155 Cognitive behavior therapy has fared as well as antidepressant med

156 often labeled as the generic term cognitive behavior therapy, has been shown to be effective in redu

157 tary therapy, physical activity, and ongoing behavior therapy have been endorsed by the National Inst

158 rents' views of the credibility of cognitive behavior therapy improved compared with parents' views o

159 d with 18 sessions of manual-based cognitive behavior therapy in a three-site study.

160 efficacy of any psychotherapy, and cognitive behavior therapy in particular, in posthospitalization c

161 6Met genotype predicts response to cognitive behavior therapy in PTSD and is in accord with evidence

162 otherapy, we examined responses to cognitive behavior therapy in relation to electroencephalographic

163 therefore investigated response to cognitive behavior therapy in relation to pretreatment measures of

164 s of antidepressant medication and cognitive behavior therapy in the severely depressed outpatient su

165 nificantly more patients receiving cognitive behavior therapy, in relation to those in relaxation the

166 Guided self-help based on cognitive behavior therapy is a first-line treatment option for mo

167 Behavior therapy is a recommended intervention for Toure

168 Comprehensive behavior therapy is a safe and effective intervention fo

169 Cognitive behavior therapy is an effective treatment for major dep

170 tivational enhancement therapy and cognitive behavior therapy is feasible for adults with poorly cont

171 Cognitive behavior therapy is more efficacious than SBFT or NST fo

172 rapy (often labeled generically as cognitive behavior therapy) is efficacious either alone or as an a

173 e completer group, self-management cognitive behavior therapy led to greater reductions in PTSD, depr

174 nt-to-treat group, self-management cognitive behavior therapy led to sharper declines in daily log-on

175 Self-management cognitive behavior therapy may be a way of delivering effective tr

176 Cognitive behavior therapy may benefit the large number of patient

177 Behavior therapy may offer an alternative but has not be

178 Hamilton scores were lower in the cognitive behavior therapy (mean [standard error], 5.5 [1.0]) and

179 mized, controlled trials comparing cognitive behavior therapy, medication, and their combination to p

180 zed controlled trials, including dialectical behavior therapy, mentalization-based therapy, transfere

181 nged grief disorder, grief-focused cognitive behavior therapy might be the more effective choice, tak

182 ly assigned to 8 sessions during 10 weeks of behavior therapy (n = 61) or a control treatment consist

183 Cognitive behavior therapy (n = 70) conducted in the primary care

184 ndomly assigned to self-management cognitive behavior therapy (N=24) or supportive counseling (N=21).

185 mmended standard treatment (either cognitive behavior therapy [N=36] or imipramine [N=22]).

186 rvention (8 weeks of manual-guided cognitive behavior therapy) (n = 90), or referral to community men

187 complete data) or Internet behavior therapy (behavior therapy; n = 33 with complete data).

188 Neither treatment with cognitive behavior therapy nor less severe major depression predic

189 g and the acknowledged preclinical model for behavior therapy of human anxiety.

190 ty during pregnancy through use of Cognitive Behavior Therapy, on birth outcomes with 796 women in Rw

191 randomly assigned to 20 weeks of dialectical behavior therapy or 20 weeks of a waiting-list compariso

192 cted to receive 1 year of either dialectical behavior therapy or general psychiatric management for b

193 One year of either dialectical behavior therapy or general psychiatric management was a

194 isorder than treatment with either cognitive behavior therapy or imipramine; results obtained with em

195 e treated for 16 weeks with either cognitive behavior therapy or interpersonal psychotherapy alone (p

196 ad relapsed following, a course of cognitive behavior therapy or interpersonal psychotherapy were ran

197 0-minute sessions of grief-focused cognitive behavior therapy or mindfulness-based cognitive therapy

198 y assigned to 1 year of outpatient cognitive behavior therapy or nutritional counseling.

199 signed to receive the two kinds of cognitive behavior therapy or received standard community treatmen

200 Twelve weeks of cognitive behavior therapy or supportive stress management.

201 n = 139) were randomly assigned to cognitive behavior therapy or usual care for depression.

202 nsference-focused psychotherapy, dialectical behavior therapy, or supportive treatment and received m

203 rbid posttraumatic stress disorder (PTSD) on behavior therapy outcome for obsessive-compulsive disord

204 en the six genetic risk scores and cognitive behavior therapy outcome.

205 Interventions: Site-specific behavior therapy plus 10 mg of sibutramine or placebo.

206 tinction of the additive effect of cognitive behavior therapy plus motivational enhancement therapy f

207 bined psychotherapy (8 sessions of cognitive behavior therapy) plus pharmacotherapy (citalopram).

208 Cognitive-behavioral therapy and dialectical behavior therapy prevent suicidal behavior.

209 underwent an 8-week exposure-based cognitive behavior therapy program and provided mouth swabs or sal

210 Sibutramine added to a behavior therapy program reduced BMI and body weight mor

211 In addition, adherence to the cognitive behavior therapy prototype yielded more positive correla

212 Behavior therapy remains the recommended first-line trea

213 ograms were complying with the new cognitive behavior therapy requirement.

214 Behavior therapy responders had significant (P < .05) bi

215 tion between sleep abnormality and cognitive behavior therapy response was not significant in the com

216 Behavior therapy resulted in a greater reduction in slee

217 Cognitive behavior therapy resulted in more rapid relief in interv

218 he interpersonal psychotherapy and cognitive behavior therapy sessions adhered most strongly to the i

219 of interpersonal psychotherapy and cognitive behavior therapy sessions conducted as part of the NIMH

220 One hour before each of the behavior therapy sessions, the participants received eit

221 were offered additional in-person cognitive behavior therapy sessions.

222 Then they received 10 behavior therapy sessions.

223 Cognitive behavior therapy showed a lower rate of MDD at the end o

224 ion (n = 6227) that introduced 4 dialectical behavior therapy skills (mindfulness, mindfulness of cur

225 of self-harm, and offering brief dialectical behavior therapy skills training significantly increased

226 Both groups receiving cognitive behavior therapy sustained greater improvement in substa

227 d to 1 of 3 treatments: individual cognitive behavior therapy, systemic behavior family therapy (SBFT

228 Use of a specialist behavior therapy team in addition to standard treatment

229 ts associated with treatment by a specialist behavior therapy team.

230 Community-based specialist behavior therapy teams may be helpful in managing challe

231 striction, increasing physical activity, and behavior therapy techniques.

232 52 [74%]) examined trauma-focused cognitive behavior therapies (TF-CBTs).

233 rventions - such as trauma-focused cognitive behavior therapy (TF-CBT) and eye movement desensitizati

234 More participants in the behavior therapy than education group achieved the 5% we

235 can lead to the development of drugs and/or behavior therapies that reduce the impact that these cue

236 mpare the efficacy of a manualized cognitive behavior therapy that addresses both posttraumatic stres

237 (seeking safety) with a manualized cognitive behavior therapy that addresses only substance abuse (re

238 After behavior therapy the patients evidenced significant decr

239 d after 16 weeks of treatment with cognitive behavior therapy to determine the stability or reversibi

240 d treatment is for the addition of cognitive behavior therapy to pharmacotherapy for patients with ag

241 borderline personality disorder: dialectical behavior therapy, transference-focused psychotherapy, an

242 tients with BED, with IPT (or full cognitive behavior therapy) used for patients with low self-esteem

243 ef interpersonal psychotherapy and cognitive behavior therapy using the Psychotherapy Process Q-Set,

244 d, Internet-based, self-management cognitive behavior therapy versus Internet-based supportive counse

245 n a randomized controlled trial of cognitive behavior therapy versus relaxation therapy for chronic f

246 evaluated the long-term outcome of cognitive behavior therapy versus relaxation therapy for patients

247 Behavior therapy was associated with a significantly gre

248 Dialectical behavior therapy was associated with better outcomes in

249 D-cycloserine versus placebo augmentation of behavior therapy was conducted in 23 OCD patients.

250 Cognitive behavior therapy was initiated at a median of 17 days af

251 Response to inpatient cognitive behavior therapy was inversely associated with pretreatm

252 Cognitive behavior therapy was markedly underused.

253 Cognitive behavior therapy was positively evaluated and was still

254 Cognitive behavior therapy was significantly more effective than n

255 Cognitive behavior therapy was superior to usual care at most poin

256 s of antidepressant medication and cognitive behavior therapy were compared within each of the four s

257 patients with major depression to cognitive behavior therapy were complex and that future efforts sh

258 erence-focused psychotherapy and dialectical behavior therapy were significantly associated with impr

259 Patients receiving behavior therapy who were available for assessment at 6

260 is study examined the efficacy of augmenting behavior therapy with D-cycloserine (DCS) to reduce tic

261 ariance treatment (escitalopram or cognitive behavior therapy) x outcome (remission or nonresponse) i